New Drug Shows 97 Percent Effectiveness Against Malaria
A new malaria treatment known as ganaplacide/lumefantrine, also called GanLum, has demonstrated a 97 percent success rate in fighting malaria. The drug was developed by Swiss pharmaceutical company Novartis in partnership with Medicines for Malaria Venture (MMV). Successful Phase Three Clinical Trials The results were announced after Phase Three clinical trials involving 1,688 participants, including…
